Insulin pens and vials According to the complaint, PillPack would dispense and bill for a full carton of insulin pens and falsely underreport the days of supply. (Photo: Daniel Beckemeier/Shutterstock.com)

The United States has settled a health care fraud lawsuit against online retail pharmacy PillPack LLC, a wholly owned subsidiary of Amazon.com Inc. The move resolves allegations that PillPack improperly billed government health care programs — including Medicare and Medicaid — for more insulin pens than patients needed based on their prescriptions and falsely under-reported the "days of supply" of insulin dispensed.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Core and Group Health
Employee-Paid
Employer-Paid
Investment Instruments